We are thrilled to unveil our brand-new website, showcasing the revolutionary Multifunctional Transdermal Carrier Y (MTC-Y™) technology developed by Biotts, a global leader in Transdermal Drug Delivery.

Our Biotts team – Dr. Paweł Biernat, CEO & Transdermal Systems Specialist, and Jan Hendriks, CBO, took part in the annual conference Advanced Technologies & Treatments for Diabetes (ATTD) 2023 in Berlin.

It’s official: Biotts has reached another important milestone in its development!
The Chief Pharmaceutical Inspectorate has granted Biotts a license to manufacture and import medicinal products – thanks to this consent, our scientists can start clinical trials on humans in the first quarter of 2023.

The 5 Forum Nowoczesnej Diabetologii (5th Forum of Modern Diabetology) has ended. One of the event’s highlights was a contest that featured the most innovative project/product supporting the treatment and self-management of patients with diabetes.

We’re excited to let you know about another big “win” for Biotts: The Lower Silesia Voucher for Innovation will allow for the further development of our technology. – We will use the grant to analyze the molecular structure of our transdermal carrier. The subject of the study carried out by the University of Opole will […]

CPHI Frankfurt – the event that brings together pharmaceutical professionals from around the world – has ended. Over the past few days Pawel Biernat – CEO of Biotts – had the opportunity to not only meet, but also talk with the people behind the innovative solutions which are defining the future of the medical industry. […]